» Articles » PMID: 23500439

Hydroxyapatite-fucoidan Nanocomposites for Bone Tissue Engineering

Overview
Publisher Elsevier
Date 2013 Mar 19
PMID 23500439
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Hydroxyapatite (HAp) is the promising biomaterials to construct the article bone from the last two decades. In the present study, we have developed hydroxyapatite-fucoidan (HApF) nanocomposite for bone tissue engineering and subsequently characterized by different analytical techniques for bone graft substitute. The chemical characterization suggested that the prepared nanocomposite HApF have amorphous nature, crystal size between 41 and 153 nm was observed. The biochemical characterization inferred that the prepared nanocomposite were non-toxic and mineralization effect of HApF was observed two times higher then HAp. Hence, HApF is the promising biomaterial and could be used for bone tissue construct.

Citing Articles

Sulfated galactofucan from Sargassum fusiforme protects against postmenopausal osteoporosis by regulating bone remodeling.

Yizhong B, Chen F, Jin W, Dai J, Mao G, Song B Commun Biol. 2024; 7(1):1471.

PMID: 39516319 PMC: 11549216. DOI: 10.1038/s42003-024-07097-2.


The Effects of Fucoidan Derived from and on the Survival and Mineralisation of Osteogenic Progenitors.

Gupta D, Martinez D, Puertas-Mejia M, Hearnden V, Reilly G Int J Mol Sci. 2024; 25(4).

PMID: 38396762 PMC: 10889223. DOI: 10.3390/ijms25042085.


Development of a Novel Marine-Derived Tricomposite Biomaterial for Bone Regeneration.

Aslam B, Augustyniak A, Clarke S, McMahon H Mar Drugs. 2023; 21(9).

PMID: 37755086 PMC: 10532529. DOI: 10.3390/md21090473.


Unveiling the secrets of marine-derived fucoidan for bone tissue engineering-A review.

V K A, Udduttula A, Jaiswal A Front Bioeng Biotechnol. 2023; 10:1100164.

PMID: 36698636 PMC: 9868180. DOI: 10.3389/fbioe.2022.1100164.


Fucoidan-Incorporated Composite Scaffold Stimulates Osteogenic Differentiation of Mesenchymal Stem Cells for Bone Tissue Engineering.

G V Y, Nagendra A, P S, Chatterjee K, Venkatesan J Mar Drugs. 2022; 20(10).

PMID: 36286414 PMC: 9604642. DOI: 10.3390/md20100589.